CENIT AG (CSH.DE) Fundamental Analysis & Valuation

FRA:CSH • DE0005407100

Current stock price

6.68 EUR
+0.12 (+1.83%)
Last:

This CSH.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CSH.DE Profitability Analysis

1.1 Basic Checks

  • CSH had negative earnings in the past year.
  • In the past year CSH had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: CSH reported negative net income in multiple years.
  • In the past 5 years CSH always reported a positive cash flow from operatings.
CSH.DE Yearly Net Income VS EBIT VS OCF VS FCFCSH.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M

1.2 Ratios

  • CSH has a Return On Assets (-0.85%) which is comparable to the rest of the industry.
  • The Return On Equity of CSH (-3.06%) is comparable to the rest of the industry.
  • Looking at the Return On Invested Capital, with a value of 0.25%, CSH is in line with its industry, outperforming 48.21% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CSH is significantly below the industry average of 12.32%.
  • The last Return On Invested Capital (0.25%) for CSH is well below the 3 year average (4.43%), which needs to be investigated, but indicates that CSH had better years and this may not be a problem.
Industry RankSector Rank
ROA -0.85%
ROE -3.06%
ROIC 0.25%
ROA(3y)0.28%
ROA(5y)2.07%
ROE(3y)0.92%
ROE(5y)5.47%
ROIC(3y)4.43%
ROIC(5y)5.44%
CSH.DE Yearly ROA, ROE, ROICCSH.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20

1.3 Margins

  • CSH has a Operating Margin of 0.15%. This is comparable to the rest of the industry: CSH outperforms 48.21% of its industry peers.
  • In the last couple of years the Operating Margin of CSH has declined.
  • CSH has a Gross Margin of 60.07%. This is comparable to the rest of the industry: CSH outperforms 40.18% of its industry peers.
  • In the last couple of years the Gross Margin of CSH has grown nicely.
Industry RankSector Rank
OM 0.15%
PM (TTM) N/A
GM 60.07%
OM growth 3Y-25.28%
OM growth 5Y-9.08%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.43%
GM growth 5Y4.24%
CSH.DE Yearly Profit, Operating, Gross MarginsCSH.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. CSH.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CSH is destroying value.
  • CSH has about the same amout of shares outstanding than it did 1 year ago.
  • CSH has about the same amout of shares outstanding than it did 5 years ago.
  • The debt/assets ratio for CSH has been reduced compared to a year ago.
CSH.DE Yearly Shares OutstandingCSH.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
CSH.DE Yearly Total Debt VS Total AssetsCSH.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 2.21 indicates that CSH is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.21, CSH is in line with its industry, outperforming 54.46% of the companies in the same industry.
  • The Debt to FCF ratio of CSH is 3.33, which is a good value as it means it would take CSH, 3.33 years of fcf income to pay off all of its debts.
  • CSH has a Debt to FCF ratio (3.33) which is comparable to the rest of the industry.
  • CSH has a Debt/Equity ratio of 0.95. This is a neutral value indicating CSH is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.95, CSH is doing worse than 78.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 3.33
Altman-Z 2.21
ROIC/WACC0.03
WACC7.39%
CSH.DE Yearly LT Debt VS Equity VS FCFCSH.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.3 Liquidity

  • A Current Ratio of 1.28 indicates that CSH should not have too much problems paying its short term obligations.
  • CSH has a Current ratio (1.28) which is comparable to the rest of the industry.
  • CSH has a Quick Ratio of 1.28. This is a normal value and indicates that CSH is financially healthy and should not expect problems in meeting its short term obligations.
  • CSH's Quick ratio of 1.28 is in line compared to the rest of the industry. CSH outperforms 44.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 1.28
CSH.DE Yearly Current Assets VS Current LiabilitesCSH.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. CSH.DE Growth Analysis

3.1 Past

  • CSH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1579.07%.
  • Looking at the last year, CSH shows a small growth in Revenue. The Revenue has grown by 1.05% in the last year.
  • The Revenue has been growing slightly by 7.31% on average over the past years.
EPS 1Y (TTM)-1579.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%342.98%
Revenue 1Y (TTM)1.05%
Revenue growth 3Y8.92%
Revenue growth 5Y7.31%
Sales Q2Q%-1.06%

3.2 Future

  • Based on estimates for the next years, CSH will show a very strong growth in Earnings Per Share. The EPS will grow by 79.38% on average per year.
  • The Revenue is expected to grow by 4.87% on average over the next years.
EPS Next Y128.57%
EPS Next 2Y79.38%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.95%
Revenue Next 2Y8.32%
Revenue Next 3Y6.67%
Revenue Next 5Y4.87%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CSH.DE Yearly Revenue VS EstimatesCSH.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50M 100M 150M 200M 250M
CSH.DE Yearly EPS VS EstimatesCSH.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5

More info and screens

Find the best growth stocksShow best growing peers

4

4. CSH.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CSH. In the last year negative earnings were reported.
  • The Price/Forward Earnings ratio is 47.24, which means the current valuation is very expensive for CSH.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CSH is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 21.68, CSH is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 47.24
CSH.DE Price Earnings VS Forward Price EarningsCSH.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, CSH is valued cheaper than 97.32% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.48
EV/EBITDA N/A
CSH.DE Per share dataCSH.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

  • CSH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CSH's earnings are expected to grow with 79.38% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y79.38%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. CSH.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.15%, CSH is a good candidate for dividend investing.
  • CSH's Dividend Yield is rather good when compared to the industry average which is at 0.74. CSH pays more dividend than 94.64% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, CSH pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.15%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CSH.DE Yearly Dividends per shareCSH.DE Yearly Dividends per shareYearly Dividends per share 2019 2021 2022 2023 2024 0.2 0.4 0.6

5.3 Sustainability

DP0%
EPS Next 2Y79.38%
EPS Next 3YN/A
CSH.DE Yearly Income VS Free CF VS DividendCSH.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M

More info and screens

Find the best dividend stocksShow peers with best dividend

CSH.DE Fundamentals: All Metrics, Ratios and Statistics

CENIT AG

FRA:CSH (4/30/2026, 3:44:39 PM)

6.68

+0.12 (+1.83%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Industry Strength12.16
Industry Growth60.67
Earnings (Last)04-09
Earnings (Next)05-13
Inst Owners45%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap55.91M
Revenue(TTM)209.51M
Net Income(TTM)-1.21M
Analysts90
Price Target13.26 (98.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.15%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.89%
PT rev (3m)-1.89%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.8%
Revenue NY rev (3m)-0.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 47.24
P/S 0.27
P/FCF 4.48
P/OCF 3.96
P/B 1.41
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)0.14
Fwd EY2.12%
FCF(TTM)1.49
FCFY22.34%
OCF(TTM)1.69
OCFY25.27%
SpS25.03
BVpS4.73
TBVpS-1.88
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -0.85%
ROE -3.06%
ROCE 0.36%
ROIC 0.25%
ROICexc 0.31%
ROICexgc 1.47%
OM 0.15%
PM (TTM) N/A
GM 60.07%
FCFM 5.96%
ROA(3y)0.28%
ROA(5y)2.07%
ROE(3y)0.92%
ROE(5y)5.47%
ROIC(3y)4.43%
ROIC(5y)5.44%
ROICexc(3y)5.58%
ROICexc(5y)8.09%
ROICexgc(3y)20.51%
ROICexgc(5y)21.52%
ROCE(3y)6.29%
ROCE(5y)8.32%
ROICexgc growth 3Y-6.11%
ROICexgc growth 5Y0.23%
ROICexc growth 3Y-22.63%
ROICexc growth 5Y-18.84%
OM growth 3Y-25.28%
OM growth 5Y-9.08%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.43%
GM growth 5Y4.24%
F-Score5
Asset Turnover1.47
Health
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 3.33
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.78%
Interest Coverage 0.12
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.28
Quick Ratio 1.28
Altman-Z 2.21
F-Score5
WACC7.39%
ROIC/WACC0.03
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.75%
Cap/Sales(5y)0.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1579.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%342.98%
EPS Next Y128.57%
EPS Next 2Y79.38%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.05%
Revenue growth 3Y8.92%
Revenue growth 5Y7.31%
Sales Q2Q%-1.06%
Revenue Next Year11.95%
Revenue Next 2Y8.32%
Revenue Next 3Y6.67%
Revenue Next 5Y4.87%
EBIT growth 1Y-95.84%
EBIT growth 3Y-18.62%
EBIT growth 5Y-2.43%
EBIT Next Year1946.12%
EBIT Next 3Y201%
EBIT Next 5Y94.96%
FCF growth 1Y41.73%
FCF growth 3Y7.04%
FCF growth 5Y1.7%
OCF growth 1Y36.69%
OCF growth 3Y7.14%
OCF growth 5Y2.85%

CENIT AG / CSH.DE Fundamental Analysis FAQ

What is the fundamental rating for CSH stock?

ChartMill assigns a fundamental rating of 4 / 10 to CSH.DE.


What is the valuation status of CENIT AG (CSH.DE) stock?

ChartMill assigns a valuation rating of 4 / 10 to CENIT AG (CSH.DE). This can be considered as Fairly Valued.


What is the profitability of CSH stock?

CENIT AG (CSH.DE) has a profitability rating of 4 / 10.


What is the financial health of CENIT AG (CSH.DE) stock?

The financial health rating of CENIT AG (CSH.DE) is 4 / 10.